Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Trinity Bio ADR (TRIB) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 166,950
  • Shares Outstanding, K 23,710
  • Annual Sales, $ 100,200 K
  • Annual Income, $ 21,800 K
  • 36-Month Beta 1.17
  • Price/Sales 1.65
  • Price/Book 0.79

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.71 +4.02%
on 01/09/17
7.27 -3.99%
on 12/20/16
+0.09 (+1.31%)
since 12/16/16
3-Month
6.52 +7.06%
on 11/04/16
7.40 -5.68%
on 11/15/16
+0.22 (+3.25%)
since 10/17/16
52-Week
5.76 +21.18%
on 10/04/16
13.68 -48.98%
on 08/29/16
-3.83 (-35.43%)
since 01/15/16

Most Recent Stories

More News
The Top 200 IVD Companies Worldwide

Did you know?

Bragar Eagel & Squire, P.C. Is Investigating Trinity Biotech plc (TRIB) on Behalf of Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. is investigating potential claims against Trinity Biotech plc (NASDAQ:TRIB) concerning possible violations of the federal securities laws.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Trinity Biotech plc and Certain Officers and Directors -- TRIB

Levi & Korsinsky, LLP announces that it has commenced an investigation of Trinity Biotech plc ("Trinity" or the "Company") (NASDAQ: TRIB) concerning possible violations of federal securities laws by the...

Trinity Biotech announces Quarter 3 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September...

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Trinity Biotech plc and Advises Investors with Losses to Contact the Firm

Lundin Law PC (http://lundinlawpc.com/) announces that it is investigating claims against Trinity Biotech plc ("Trinity" or the "Company") (Nasdaq: TRIB) concerning possible violations...

Trinity Biotech plc to Announce Third Quarter Fiscal Year 2016 Financial Results

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter...

The Top 200 IVD Companies Worldwide

Did you know?

Research and Markets - Global Antinuclear Antibody Test Market Worth $1,476.1 Million by 2021 - Key Players are Bio-Rad Laboratories, ERBA Diagnostics & Trinity Biotech

DUBLIN, October 10, 2016 /PRNewswire/ --

Research and Markets - Global Antinuclear Antibody Test Market Worth $1,476.1 Million by 2021 - Key Players are Bio-Rad Laboratories, ERBA Diagnostics & Trinity Biotech

Research and Markets has announced the addition of the "Antinuclear Antibody Test Market - Forecast to 2021" report to their offering.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Trinity Biotech plc and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Trinity Biotech plc ("Trinity" or the "Company") (Nasdaq: TRIB) concerning possible violations of federal...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators are in flux.

See More

Business Summary

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and...

See More

Support & Resistance

2nd Resistance Point 7.10
1st Resistance Point 7.04
Last Price 6.98
1st Support Level 6.93
2nd Support Level 6.88

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.